Cerebral infusion of 6-HDA does induce the lesions in rats. E.g., Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats. Food Chem. 2013 Jun 1;138(2-3):1028-33. doi: 10.1016/j.foodchem.2012.11.022. Epub 2012 Nov 16.
Yes you can prepare model for parkinson disease by intracerebral injection of 6- OHDA 2 to induce Parkinson in rats. Please go through this paper.
Redox Rep. 2005;10(2):103-9.
Involvement of nitric oxide in neurodegeneration: a study on the experimental models of Parkinson's disease.
Singh S1, Das T, Ravindran A, Chaturvedi RK, Shukla Y, Agarwal AK, Dikshit M.
Author information
Abstract
The present study was undertaken to explore involvement of nitric oxide (NO) in the experimental models of Parkinson's disease. Neurodegeneration was induced by unilateral injections of 6-hydroxydopamine (6-OHDA) or lipopolysaccharide (LPS) in the right striatum. Lesions were functionally evaluated by amphetamine-induced asymmetrical behaviour and by decrease in the tyrosine hydroxylase (TH) immunostaining. An induction in the expression of iNOS and augmentation in nitrite content was observed in both the models. The extent of increase in iNOS expression was, however, different but the elevation in the nitrite content was comparable in both the models. The increase in iNOS expression inversely correlated with the tyrosine hydroxylase (TH) immunolabeling. Animals pretreated with a NOS inhibitor, N(G)-nitro-L-arginine methyl ester (L-NAME), exhibited complete protection against amphetamine induced rotations in both the models. Thus, augmented NO availability subsequent to iNOS induction seems to play an important role in the initial phase of neurodegeneration.
Yes you can develop parkinson like symptoms in rat by 6OHDA infusion. Take a look at the Romulo's science paper attached here. Also you can look at some other articles from Miguel Nicolelis lab at Duke Univ. where some graduate students and postdocs are using 6-OHDA for developing parkinsonism in rat. You can talk to Amol Yadava (graduate student) in the same lab who is currently working on developing parkinson disease in animal models.
@S K Sharma Sir we don't have steriotaxic frame in King George's Medical University Lucknow thats why we are looking 4 alternate methods of inducing Parkinsonism
For the 6-OHDA model the injections need to be precise, a steriotaxic frame would be of great importance. You could try finding a used a steriotaxic frame to buy.
What you want is an "intracisternal" (actually 4th ventricle) injection, using a 1/4" needle. Use 200ug of 6-OHDA.Br (calculated as the base), with 0.2 mg/ml ascorbic acid in 25 ul 0.85% saline: Hedreen JC, Chalmers JP Neuronal degeneration in rat brain induced by 6-hydroxydopamine; a histological and biochemical study. Brain Res. 47:1-36, 1972.
For additional remarks and cautions see also: Hedreen J Neuronal degeneration caused by lateral ventricular injection of 6-hydroxydopamine. I. The ventral premammillary nucleus and other cell groups. Brain Res. 157:129-135, 1978. (& also Brain Res Bull 5:425-436, 1980; further literature quoted in these two latter papers).